CTLA4 and colitis: The Mediterranean diet must be researched further, in order to determine its influence on the Firmicutes levels [54,60], which could affect the immunotherapy’s effectiveness, due to its connection with a higher risk of colitis caused by CTLA-4 therapy [21].